There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C12N9/22
Jump to navigation
Jump to search
Pages in category "C12N9/22"
The following 58 pages are in this category, out of 58 total.
1
- 17273688. BASE EDITING FOR TREATING HUTCHINSON-GILFORD PROGERIA SYNDROME simplified abstract (Vanderbilt University)
- 17735222. POLYPEPTIDE VARIANTS simplified abstract (The Procter & Gamble Company)
- 17928516. QPT GENE ENGINEERED PLANT CELL AND USING METHOD OF THE SAME simplified abstract (KT&G CORPORATION)
- 18007439. GENE CORRECTION FOR SCID-X1 IN LONG-TERM HEMATOPOIETIC STEM CELLS simplified abstract (THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY)
- 18064738. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES simplified abstract (President and Fellows of Harvard College)
- 18104640. METHODS AND KITS FOR IDENTIFYING CANCER TREATMENT TARGETS simplified abstract (The Regents of the University of California)
- 18130199. RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18130202. RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USE THEREOF simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18167598. Compositions and Methods of Treating Ocular Diseases simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18234690. RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX simplified abstract (Massachusetts Institute of Technology)
- 18246420. PRIME EDITING-BASED GENE EDITING COMPOSITION WITH ENHANCED EDITING EFFICIENCY AND USE THEREOF simplified abstract (KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION)
- 18246420. PRIME EDITING-BASED GENE EDITING COMPOSITION WITH ENHANCED EDITING EFFICIENCY AND USE THEREOF simplified abstract (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
- 18272355. HIV Pseudovirus Particles and Method for Preparing the Same simplified abstract (BOE Technology Group Co., Ltd.)
- 18273579. MODULATION OF A PATHOGENIC PHENOTYPE IN TH1 CELLS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18282421. Compositions and Methods for the Treatment of Conditions Associated with Nucleotide Repeat Expansion simplified abstract (The General Hospital Corporation)
- 18295036. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation)
- 18298942. SYNTHETIC TRANSCRIPTION FACTORS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18324928. CRISPR ENABLED MULTIPLEXED GENOME ENGINEERING simplified abstract (THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE)
- 18352037. FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS simplified abstract (Duke University)
- 18449940. DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS simplified abstract (Massachusetts Institute of Technology)
- 18459484. METHODS AND COMPOSITIONS FOR GENERATING COMPLEX TRAIT LOCI simplified abstract (PIONEER HI-BRED INTERNATIONAL, INC.)
- 18463589. TARGETED NON-VIRAL DNA INSERTIONS simplified abstract (The Regents of the University of California)
- 18472881. RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY simplified abstract (Duke University)
- 18551975. GENE CORRECTION FOR RAG2 DEFICIENCY IN HUMAN STEM CELLS simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18556857. NEGATIVE-STRAND RNA VIRAL VECTOR AND PLANT GENOME EDITING METHOD WITHOUT TRANSFORMATION simplified abstract (Zhejiang University)
- 18558052. MULTIPLEXED UNBIASED NUCLEIC ACID AMPLIFICATION METHOD simplified abstract (Becton, Dickinson and Company)
- 18558122. MULTICOMPONENT XNAZYME-BASED NUCLEIC ACID DETECTION SYSTEM simplified abstract (The Regents of the University of California)
- 18558992. COMPOSITIONS COMPRISING NULLOMERS AND METHODS OF USING THE SAME FOR CANCER DETECTION AND DIAGNOSIS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
2
- 20240008460. JAK3 GENE-MUTATED, SEVERE COMBINED IMMUNODEFICIENCY ANIMAL MODEL AND CONSTRUCTION METHOD THEREFOR simplified abstract (KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY)
- 20240008461. CRUCIAN CARP (CARASSIUS AURATUS) STRAIN WITHOUT INTERMUSCULAR BONES AND BREEDING METHOD THEREOF simplified abstract (HEILONGJIANG RIVER FISHERIES RESEARCH INSTITUTE OF CHINESE ACADEMY OF FISHERY SCIENCES)
A
B
- Biotechnology patent applications on 5th Jul 2024
- Biotechnology patent applications on August 8th, 2024
- Biotechnology patent applications on July 4th, 2024
- Biotechnology patent applications on May 30th, 2024
- Blockchain patent applications on April 18th, 2024
- Blockchain patent applications on April 4th, 2024
- Blockchain patent applications on January 11th, 2024
- Blockchain patent applications on March 14th, 2024
- Blockchain patent applications on May 16th, 2024
C
D
T
- The regents of the university of california (20240252678). SYNTHETIC EXOSOMES (SE) FOR CNS DELIVERY OF CRISPR FOR GENE EDITING IN BRAIN DISORDERS simplified abstract
- The Regents of the University of California patent applications on August 1st, 2024
- TOYOTA JIDOSHA KABUSHIKI KAISHA patent applications on February 8th, 2024
U
- US Patent Application 18248252. TYPE I CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS simplified abstract
- US Patent Application 18249865. NUCLEIC ACID-GUIDED NUCLEASES AND USE THEREOF simplified abstract
- US Patent Application 18303533. SITE SPECIFIC GENETIC ENGINEERING UTILIZING TRANS-TEMPLATE RNAS simplified abstract
- US Patent Application 18322675. SYSTEMS, METHODS, AND COMPOSITIONS FOR RNA-GUIDED RNA-TARGETING CRISPR EFFECTORS simplified abstract
- US Patent Application 18334046. TYPE VI CRISPR ORTHOLOGS AND SYSTEMS simplified abstract
- US Patent Application 18365040. HIGH-THROUGHPUT PRECISION GENOME EDITING simplified abstract
